Genomewide Association Study Identifies Cxcl Family Members as Partial Mediators of LPS-Induced Periodontitis

J Bone Miner Res. 2018 Aug;33(8):1450-1463. doi: 10.1002/jbmr.3440. Epub 2018 May 22.

Abstract

Periodontitis (PD) is characterized by bacterial infection and inflammation of tooth-supporting structures and can lead to tooth loss. PD affects ∼47% of the US population over age 30 years and has a heritability of about 50%. Although the host immunoinflammatory response and genetic background play a role, little is known of the underlying genetic factors. We examined natural genetic variation in lipopolysaccharide (LPS)-induced PD across a panel of inbred mouse strains, the hybrid mouse diversity panel (HMDP). We observed a strain-dependent sixfold difference in LPS-induced bone loss across the HMDP with a heritability of 53%. We performed a genomewide association study (GWAS) using FAST-LMM, which corrects for population structure, and identified loci significantly associated with PD. We examined candidate genes at a locus on chromosome 5, which suggested a relationship between LPS-induced bone loss and, together with expression data, identified Cxcl family members as associated with PD. We observed an increase in Cxcl10 protein, as well as immune cells and pro-inflammatory cytokines in C57BL/6J (high bone loss strain) but not in A/J (low bone loss strain) after LPS injections. Genetic deletion of CXCR3 (Cxcl9 and10 receptor) demonstrated a ∼50% reduction in bone loss and reduced osteoclasts after LPS injections. Furthermore, WT mice treated with AMG-487 (a CXCR3 antagonist) showed a ∼45% reduction in bone loss and decreased osteoclasts after LPS injections. We conclude that CXCR3 is a strong candidate for modulating the host response in individuals susceptible to PD. © 2018 American Society for Bone and Mineral Research.

Keywords: ANIMAL MODELS; DENTAL BIOLOGY; DISEASES AND DISORDERS OF/RELATED TO BONE; GENETIC ANIMAL MODELS; PERIODONTAL DISEASE; PERIODONTITIS; THERAPEUTICS.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / administration & dosage
  • Acetamides / pharmacology
  • Alveolar Bone Loss / complications
  • Alveolar Bone Loss / genetics
  • Alveolar Bone Loss / pathology
  • Animals
  • Biomarkers / metabolism
  • Chemokines, CXC / genetics*
  • Chemokines, CXC / metabolism
  • Female
  • Gene Expression Regulation
  • Genome-Wide Association Study*
  • Inflammation Mediators / metabolism
  • Lipopolysaccharides
  • Macrophages / metabolism
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Osteoclasts / metabolism
  • Osteoclasts / pathology
  • Periodontitis / complications
  • Periodontitis / diagnostic imaging
  • Periodontitis / genetics*
  • Polymorphism, Single Nucleotide / genetics
  • Pyrimidinones / administration & dosage
  • Pyrimidinones / pharmacology
  • Receptors, CXCR3 / antagonists & inhibitors
  • Receptors, CXCR3 / metabolism

Substances

  • Acetamides
  • Biomarkers
  • Chemokines, CXC
  • Cxcr3 protein, mouse
  • Inflammation Mediators
  • Lipopolysaccharides
  • N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydropyrido(2,3-d)pyrimidin-2-yl)ethyl)-N-pyridin-3-ylmethyl-2-(4-trifluoromethoxyphenyl)acetamide
  • Pyrimidinones
  • Receptors, CXCR3